Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Directors of Israel’s Teva Pharmaceuticals Cut Their Salaries in Half
Error: Contact form not found.
by Reuters and Algemeiner Staff
A Teva building in Jerusalem. Photo: Reuters / Ammar Awad.
The board of directors at Teva Pharmaceutical Industries, which is reducing its workforce by more than a quarter as part of a global overhaul, has taken a 50 percent pay cut, a board member said on Wednesday.
The world’s biggest generic drugmaker announced its cost-cutting plan last month, setting a target to reduce costs by $3 billion by the end of 2019, from about $16.1 billion in 2017.
“This pay cut that the board took upon itself was done the same day that the cuts and job reductions were discussed,” board member Dan Suesskind said at the Israel Business Conference in Jerusalem.
The Israeli company, which is laden with heavy debt, said it would reduce its workforce by 14,000 jobs.
